profit from every $100 of sales.
$0$100
Nu Skin Enterprises
$3.89-3.47% today
-59.4% in 1 year
1-year low $3.891-year high $11.54
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $1.18 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Nu Skin Enterprises sold, what it kept, and what it did with the cash.
Sales went from $2.23 billion in 2022 to $1.49 billion in 2025, with $160 million of profit last year.
SalesProfit
Nu Skin Enterprises handed back 69% of the cash it generated last year.
Buybacks $20M$12M
Free cash flow 2025$46M
Bought back its own shares$20M
Paid as dividends$12M
Cash vs. debt$239M vs. $307M
Nu Skin Enterprises vs. similar companies
Nu Skin Enterprises grows the slowest of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Nu Skin Enterprises | 1.2× · Cheap | ||
 Procter & Gamble | 24.2× · Fair price | ||
 L'Oréal | 38.9× · Expensive | ||
 Unilever | 13.5× · Cheap | ||
 Colgate-Palmolive | 36.5× · Expensive |
AI analysis
An AI analyst reads Nu Skin Enterprises's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,226 | 1,969 | 1,732 | 1,485 | |
| 1,595 | 1,357 | 1,182 | 1,031 | |
| 159 | 68 | 51 | 91 | |
| 175 | 123 | -79 | 262 | |
| 105 | 9 | -147 | 160 | |
| 2.07 | 0.17 | -2.95 | 3.18 | |
| 71.7% | 68.9% | 68.2% | 69.4% | |
| 7.2% | 3.5% | 2.9% | 6.1% | |
| 4.7% | 0.4% | -8.5% | 10.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 1,821 | 1,809 | 1,469 | 1,405 |
| Cash | 265 | 256 | 187 | 239 |
| Total debt | 521 | 607 | 478 | 307 |
| Total liabilities | 924 | 987 | 817 | 600 |
| 897 | 822 | 651 | 805 | |
| 51 | 50 | 50 | 50 | |
| 5.7% | 2.9% | -10.4% | 14.9% | |
| 11.7% | 1.0% | -22.5% | 19.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 108 | 119 | 112 | 80 | |
| 59 | 58 | 42 | 34 | |
| 49 | 60 | 70 | 46 | |
| Dividends paid | 77 | 78 | 12 | 12 |
| 70 | 13 | 0 | 20 | |
| 12 | 16 | 15 | 24 |
Valuation
- 1.2×
- 3.9×
- 0.08
- 0.3×
- 0.1×
- 4.1×
- 1.0×
- 24.3%
- 84.6%
- 4.1%
Profitability
- 69.4%
- 6.1%
- 10.8%
- 9.0%
- 15.3%
- 3.4%
- 6.8%
- 4.0%
- 7.3%
- 0.7%
Growth
- −12.6%
- +15.4%
- −34.4%
- −30.7%
- −0.1%
Financial health
- 0.3×
- 0.38
- 20.2%
- 15.1×
- 2.08
- 1.34
- 1.05
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 22%of 670
Bottom 29%of 674
Top 1%of 624
Bottom 2%of 673
Top 3%of 668
What analysts expect
- Average price target
- $11.00
- Range
- $11.00 – $11.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 0.14 | 0.15 | −6.7% |
| Feb 12, 2026 | 0.29 | 0.30 | −3.3% |
| Nov 6, 2025 | 0.34 | 0.30 | +13.3% |
| Aug 7, 2025 | 0.43 | 0.25 | +72.0% |
| May 8, 2025 | 0.23 | 0.15 | +53.3% |
| Feb 13, 2025 | 0.38 | 0.24 | +58.3% |
| Nov 7, 2024 | 0.17 | 0.20 | −15.0% |
| Aug 8, 2024 | 0.21 | 0.18 | +16.7% |
4.1%of the share price, paid each year
On $1,000 invested$41a year at today's yield, before tax
−30.7%2020 to 2025
Raised–not every year
Paid per share, each year
$1.40 in 2015 → $0.24 in 2025
How safe it looks
7.4% of its profit
Room to growStretchedMore than it earns: 25.7%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
57No pass
Benjamin Graham
80Pass
Philip Fisher
57No pass
Peter Lynch
67Pass
Joel Greenblatt
71Pass
Charlie Munger
50No pass
Terry Smith
38No pass
Questions about Nu Skin Enterprises
Is Nu Skin Enterprises a good stock to buy?
A solid business, and the price looks low. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Nu Skin Enterprises AI analysis
What does Nu Skin Enterprises do?
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It is in Household & Personal Products.
Does Nu Skin Enterprises pay a dividend?
Yes. At today's price the dividend is 4.1% a year, about 7% of its yearly profit. In 2025 it paid out $11.8 million in dividends.
Is Nu Skin Enterprises stock halal?
No. Nu Skin Enterprises does not pass our halal screen: its debt is 162% of its market value, at or above the 33% limit. How we check
How has Nu Skin Enterprises stock done over the past year?
Down 59.4% over the past twelve months, to $3.89. It traded between $3.89 and $11.54 and is 66.3% below its high.
Who are Nu Skin Enterprises's competitors?
The largest listed companies in the same industry are Procter & Gamble, L'Oréal, Unilever and Colgate-Palmolive. The peers table on this page compares their profit, growth and price with Nu Skin Enterprises's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.